Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
1.550
-0.050 (-3.13%)
At close: Jan 31, 2025, 4:00 PM
1.510
-0.040 (-2.58%)
After-hours: Jan 31, 2025, 7:26 PM EST
Atai Life Sciences Market Cap
Atai Life Sciences has a market cap or net worth of $260.09 million as of January 31, 2025. Its market cap has decreased by -12.96% in one year.
Market Cap
260.09M
Enterprise Value
200.38M
1-Year Change
-12.96%
Ranking
Category
Stock Price
$1.55
Market Cap Chart
Since the IPO on June 18, 2021, Atai Life Sciences's market cap has decreased from $2.29B to $260.09M, a decrease of -88.63%. That is a compound annual growth rate of -45.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 31, 2025 | 260.09M | 16.54% |
| Dec 31, 2024 | 223.18M | -4.66% |
| Dec 29, 2023 | 234.07M | -46.95% |
| Dec 30, 2022 | 441.23M | -63.92% |
| Dec 31, 2021 | 1.22B | -46.56% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 739.63B |
| UnitedHealth Group | 502.12B |
| Novo Nordisk | 374.46B |
| Johnson & Johnson | 366.25B |
| AbbVie | 332.53B |
| Merck & Co. | 251.71B |
| Thermo Fisher Scientific | 229.76B |
| Abbott Laboratories | 221.87B |